Skip to main content
Menu
US

Eonis SCID-SMA kit

A PCR kit designed for the quantitative determination of Severe Combined Immunodeficiency (SCID) and x-linked Agammaglobulinemia (XLA), as well as the qualitative detection of Spinal Muscular Atrophy (SMA) using newborn dried blood spot samples.
A PCR kit designed for the quantitative determination of Severe Combined Immunodeficiency (SCID) and x-linked Agammaglobulinemia (XLA), as well as the qualitative detection of Spinal Muscular Atrophy (SMA) using newborn dried blood spot samples.
Product Variant
Unit Size: 384 reactions
Part #:
3241-0020
For in vitro diagnostic use. This product is only available where licensed in accordance with law. Please contact your local representative for availability.
Request More Information

Overview

The Eonis™ SCID-SMA kit is intended for the semi-quantitative determination of TREC (T-cell receptor excision circle) and KREC (Kappa-deleting recombination excision circle) as well as the qualitative detection of the exon 7 SMN1 gene and RPP30 (Ribonuclease P/MRP Subunit P30) gene in DNA from blood specimens dried on a filter paper as an aid in screening newborns for Severe Combined Immunodeficiency (SCID), X-linked agammaglobulinemia (XLA), and Spinal Muscular Atrophy (SMA).

Specifications

Accreditations
CE-IVD marked
Brand
Eonis™
Detection Modality
qPCR
Disorders
SCID
SMA
Instrument Compatibility
EONIS System
Sample Type
Dried blood spots
Technology
qPCR
Unit Size
384 reactions

Loading...

Scroll Icon